Literature DB >> 29500706

Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?

David John Mott1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29500706     DOI： 10.1007/s40271-018-0305-9

Source DB:  PubMed          Journal:  Patient        ISSN： 1178-1653            Impact factor:   3.883


× No keyword cloud information.
  39 in total

1.  Recommendations for benefit-risk assessment methodologies and visual representations.

Authors:  Diana Hughes; Ed Waddingham; Shahrul Mt-Isa; Alesia Goginsky; Edmond Chan; Gerald F Downey; Christine E Hallgreen; Kimberley S Hockley; Juhaeri Juhaeri; Alfons Lieftucht; Marilyn A Metcalf; Rebecca A Noel; Lawrence D Phillips; Deborah Ashby; Alain Micaleff
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-01-22       Impact factor: 2.890

2.  Welfarism, extra-welfarism and capability: the spread of ideas in health economics.

Authors:  Joanna Coast; Richard D Smith; Paula Lorgelly
Journal:  Soc Sci Med       Date:  2008-07-25       Impact factor: 4.634

3.  Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework.

Authors:  Aris Angelis; Panos Kanavos
Journal:  Soc Sci Med       Date:  2017-06-20       Impact factor: 4.634

4.  Giving Patients a Meaningful Voice in European Health Technology Assessments: The Role of Health Preference Research.

Authors:  Axel C Mühlbacher; F Reed Johnson
Journal:  Patient       Date:  2017-08       Impact factor: 3.883

5.  External Validity of Contingent Valuation: Comparing Hypothetical and Actual Payments.

Authors:  Mandy Ryan; Emmanouil Mentzakis; Suthi Jareinpituk; John Cairns
Journal:  Health Econ       Date:  2016-10-09       Impact factor: 3.046

6.  MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment.

Authors:  Tommi Tervonen; Heather Gelhorn; Sumitra Sri Bhashyam; Jiat-Ling Poon; Katharine S Gries; Anne Rentz; Kevin Marsh
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-07-11       Impact factor: 2.890

7.  WHY PATIENTS SHOULD BE INVOLVED IN HEALTH TECHNOLOGY ASSESSMENT.

Authors:  Janet Wale; Anna Mae Scott; Bjørn Hofmann; Sarah Garner; Eric Low; Lloyd Sansom
Journal:  Int J Technol Assess Health Care       Date:  2017-05-22       Impact factor: 2.188

8.  How do individuals value health states? A qualitative investigation.

Authors:  M Karimi; J Brazier; S Paisley
Journal:  Soc Sci Med       Date:  2016-11-22       Impact factor: 4.634

Review 9.  Patient and general public preferences for health states: A call to reconsider current guidelines.

Authors:  M M Versteegh; W B F Brouwer
Journal:  Soc Sci Med       Date:  2016-07-31       Impact factor: 4.634

10.  Acceptability of Financial Incentives for Health Behaviours: A Discrete Choice Experiment.

Authors:  Emma L Giles; Frauke Becker; Laura Ternent; Falko F Sniehotta; Elaine McColl; Jean Adams
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240
View more
  19 in total

1.  Do preferences differ based on respondent experience of a health issue and its treatment? A case study using a public health intervention.

Authors:  David J Mott; Laura Ternent; Luke Vale
Journal:  Eur J Health Econ       Date:  2022-06-18

2.  Value Insider Season 1 Episode 2: How to Measure Quality of Life and Utility? (QoL) [Podcast].

Authors:  Nancy J Devlin; Elisabeth Sophia Hartgers-Gubbels; Michael Chambers
Journal:  Int J Gen Med       Date:  2022-10-12

3.  Use of Patient Preference Studies in HTA Decision Making: A NICE Perspective.

Authors:  Jacoline C Bouvy; Luke Cowie; Rosemary Lovett; Deborah Morrison; Heidi Livingstone; Nick Crabb
Journal:  Patient       Date:  2020-04       Impact factor: 3.883

4.  Analysis of Patient Preferences in Lung Cancer - Estimating Acceptable Tradeoffs Between Treatment Benefit and Side Effects.

Authors:  Ellen M Janssen; Sydney M Dy; Alexa S Meara; Peter J Kneuertz; Carolyn J Presley; John F P Bridges
Journal:  Patient Prefer Adherence       Date:  2020-06-03       Impact factor: 2.711

5.  Prioritization and Refinement of Patient-Informed Value Elements as Attributes for Chronic Obstructive Pulmonary Disease Treatment Preferences.

Authors:  Julia F Slejko; Yoon Duk Hong; Jamie L Sullivan; Robert M Reed; Susan dosReis
Journal:  Patient       Date:  2021-02-08       Impact factor: 3.883

6.  Alignment of preferences in the treatment of multiple myeloma - a discrete choice experiment of patient, carer, physician, and nurse preferences.

Authors:  Simon J Fifer; Kerrie-Anne Ho; Sean Lybrand; Laurie J Axford; Steve Roach
Journal:  BMC Cancer       Date:  2020-06-11       Impact factor: 4.430

7.  Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs.

Authors:  Nigel S Cook; Julie Cave; Anke-Peggy Holtorf
Journal:  Front Med (Lausanne)       Date:  2019-04-24

8.  Discrete Choice Experiments in Health Economics: Past, Present and Future.

Authors:  Vikas Soekhai; Esther W de Bekker-Grob; Alan R Ellis; Caroline M Vass
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.981

9.  Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.

Authors:  Rosanne Janssens; Isabelle Huys; Eline van Overbeeke; Chiara Whichello; Sarah Harding; Jürgen Kübler; Juhaeri Juhaeri; Antonio Ciaglia; Steven Simoens; Hilde Stevens; Meredith Smith; Bennett Levitan; Irina Cleemput; Esther de Bekker-Grob; Jorien Veldwijk
Journal:  BMC Med Inform Decis Mak       Date:  2019-10-04       Impact factor: 2.796

10.  The Importance of Collaboration in Pursuit of Patient-Centered Value Assessment.

Authors:  Mark T Linthicum; Susan dosReis; Julia F Slejko; T Joseph Mattingly; Jennifer L Bright
Journal:  Patient       Date:  2021-07       Impact factor: 3.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.